These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15846270)

  • 1. Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) study.
    Jasper SE; Lieber EA; Murray RD; Apperson-Hansen C; Black IW; Grimm RA; Pape LA; Klein AL;
    Am Heart J; 2005 Feb; 149(2):309-15. PubMed ID: 15846270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
    Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
    J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
    Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
    Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study.
    Am J Cardiol; 1998 Apr; 81(7):877-83. PubMed ID: 9555778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
    Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
    Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
    Klein AL; Grimm RA; Black IW; Leung DY; Chung MK; Vaughn SE; Murray RD; Miller DP; Arheart KL
    Ann Intern Med; 1997 Feb; 126(3):200-9. PubMed ID: 9027270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update.
    Asher CR; Klein AL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):387-91. PubMed ID: 15071261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin.
    Akdeniz B; Türker S; Oztürk V; Badak O; Okan T; Aslan O; Kozan O; Kirimli O; Aytekin D; Bariş N; Güneri S
    Int J Cardiol; 2005 Jan; 98(1):49-55. PubMed ID: 15676166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.
    Klein AL; Murray RD; Grimm RA; Li J; Apperson-Hansen C; Jasper SE; Goodman-Bizon AS; Lieber EA; Black IW;
    Am J Cardiol; 2003 Jul; 92(2):161-5. PubMed ID: 12860217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study.
    Murray RD; Shah A; Jasper SE; Goodman A; Deitcher SR; Katz WE; Malouf JF; Stoddard MF; Grimm RA; Klein AL;
    Am Heart J; 2000 Jun; 139(6):E1-7. PubMed ID: 10827367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation and cardioversion: role of transesophageal echocardiography].
    Moreo A; Mauri F
    Ital Heart J Suppl; 2005 Dec; 6(12):780-7. PubMed ID: 16444922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transesophageal echocardiography-guided cardioversion of atrial fibrillation. Selection of a low-risk group for immediate cardioversion.
    Fonseca N; Caetano F; Santos J; Seixo F; Bernardino L; Silvestre I; Cardoso P; Segurado F; Inês L
    Rev Port Cardiol; 2004 Mar; 23(3):365-75. PubMed ID: 15185562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study.
    Klein AL; Jasper SE; Katz WE; Malouf JF; Pape LA; Stoddard MF; Apperson-Hansen C; Lieber EA;
    Eur Heart J; 2006 Dec; 27(23):2858-65. PubMed ID: 17098762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transesophageal echocardiography before cardioversion of recurrent atrial fibrillation: does absence of previous atrial thrombi preclude the need of a repeat test?
    Shen X; Li H; Rovang K; Hee T; Holmberg MJ; Mooss AN; Mohiuddin SM
    Am Heart J; 2003 Oct; 146(4):741-5. PubMed ID: 14564332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
    Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
    Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation.
    Klein AL; Murray RD; Grimm RA
    J Am Coll Cardiol; 2001 Mar; 37(3):691-704. PubMed ID: 11693739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.